Literature DB >> 26674787

B-Cell Disorders and Curcumin.

Terry Golombick1, Terrence H Diamond1, Arumugam Manoharan2, Rajeev Ramakrishna2.   

Abstract

Clinical studies with patients with early hematological malignancies (ie, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia) suggest that early intervention with curcumin, derived from the spice turmeric, may lead to prolonged survival and delay in progressive disease in some of these patients.

Entities:  

Keywords:  curcumin; integrative medicine; monoclonal gammopathy of undetermined significance; smoldering myeloma; stage 0/1 chronic lymphocytic leukemia

Mesh：

Substances：

Year:  2015        PMID： 26674787      PMCID： PMC5759937          DOI： 10.1177/1534735415622013

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN： 1534-7354            Impact factor:   3.279


  27 in total

1.  The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker.

Authors:  Terry Golombick; Terrence H Diamond; Vladimir Badmaev; Arumugam Manoharan; Rajeev Ramakrishna
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

2.  Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.

Authors:  G Dighiero; K Maloum; B Desablens; B Cazin; M Navarro; R Leblay; M Leporrier; J Jaubert; G Lepeu; B Dreyfus; J L Binet; P Travade
Journal:  N Engl J Med       Date:  1998-05-21       Impact factor: 91.245

3.  Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation.

Authors:  C Shustik; R Mick; R Silver; A Sawitsky; K Rai; L Shapiro
Journal:  Hematol Oncol       Date:  1988 Jan-Mar       Impact factor: 5.271

4.  Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance.

Authors:  T Diamond; S Levy; A Smith; P Day; A Manoharan
Journal:  Intern Med J       Date:  2001-07       Impact factor: 2.048

5.  Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Authors:  Ola Landgren; Robert A Kyle; Ruth M Pfeiffer; Jerry A Katzmann; Neil E Caporaso; Richard B Hayes; Angela Dispenzieri; Shaji Kumar; Raynell J Clark; Dalsu Baris; Robert Hoover; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

6.  Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies.

Authors:  R Bataille; D Chappard; M F Basle
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

7.  Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation.

Authors:  John Cuomo; Giovanni Appendino; Adam S Dern; Erik Schneider; Toni P McKinnon; Mark J Brown; Stefano Togni; Brian M Dixon
Journal:  J Nat Prod       Date:  2011-03-17       Impact factor: 4.050

Review 8.  The multifaceted role of curcumin in cancer prevention and treatment.

Authors:  Muthu K Shanmugam; Grishma Rane; Madhu Mathi Kanchi; Frank Arfuso; Arunachalam Chinnathambi; M E Zayed; Sulaiman Ali Alharbi; Benny K H Tan; Alan Prem Kumar; Gautam Sethi
Journal:  Molecules       Date:  2015-02-05       Impact factor: 4.411

9.  Dose escalation of a curcuminoid formulation.

Authors:  Christopher D Lao; Mack T Ruffin; Daniel Normolle; Dennis D Heath; Sandra I Murray; Joanne M Bailey; Martha E Boggs; James Crowell; Cheryl L Rock; Dean E Brenner
Journal:  BMC Complement Altern Med       Date:  2006-03-17       Impact factor: 3.659

10.  Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.

Authors:  Leticia Huergo-Zapico; Andrea Acebes-Huerta; Ana Pilar Gonzalez-Rodriguez; Juan Contesti; Esther Gonzalez-García; Angel R Payer; Monica Villa-Alvarez; Azahara Fernández-Guizán; Alejandro López-Soto; Segundo Gonzalez
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240
View more
  3 in total

Review 1.  Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.

Authors:  Moshe Frenkel; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2017-10-14       Impact factor: 5.075

Review 2.  Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.

Authors:  Md Tanvir Kabir; Md Habibur Rahman; Rokeya Akter; Tapan Behl; Deepak Kaushik; Vineet Mittal; Parijat Pandey; Muhammad Furqan Akhtar; Ammara Saleem; Ghadeer M Albadrani; Mohamed Kamel; Shaden A M Khalifa; Hesham R El-Seedi; Mohamed M Abdel-Daim
Journal:  Biomolecules       Date:  2021-03-07

Review 3.  The Anti-Leukemic Activity of Natural Compounds.

Authors:  Coralia Cotoraci; Alina Ciceu; Alciona Sasu; Eftimie Miutescu; Anca Hermenean
Journal:  Molecules       Date:  2021-05-05       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.